Personal CFO Solutions LLC Has $966,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Personal CFO Solutions LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 287.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,219 shares of the company’s stock after acquiring an additional 2,389 shares during the quarter. Personal CFO Solutions LLC’s holdings in HCA Healthcare were worth $966,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Janney Montgomery Scott LLC lifted its holdings in HCA Healthcare by 18.1% during the 3rd quarter. Janney Montgomery Scott LLC now owns 18,087 shares of the company’s stock worth $7,351,000 after purchasing an additional 2,766 shares during the last quarter. Van ECK Associates Corp acquired a new position in HCA Healthcare in the 3rd quarter valued at $752,000. Concurrent Investment Advisors LLC raised its holdings in HCA Healthcare by 26.2% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 2,703 shares of the company’s stock valued at $1,099,000 after acquiring an additional 561 shares in the last quarter. Summit Global Investments raised its holdings in HCA Healthcare by 2.8% in the 3rd quarter. Summit Global Investments now owns 3,287 shares of the company’s stock valued at $1,336,000 after acquiring an additional 88 shares in the last quarter. Finally, AIA Group Ltd raised its holdings in HCA Healthcare by 5.3% in the 3rd quarter. AIA Group Ltd now owns 2,000 shares of the company’s stock valued at $813,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HCA shares. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Royal Bank of Canada lowered their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Barclays reduced their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $330.11 on Friday. The stock’s 50 day simple moving average is $316.70 and its two-hundred day simple moving average is $347.49. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market cap of $81.27 billion, a price-to-earnings ratio of 15.03, a PEG ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the company posted $5.90 earnings per share. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s payout ratio is presently 13.11%.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.